Literature DB >> 12670398

The Wiskott-Aldrich syndrome protein: forging the link between actin and cell activation.

Karen Badour1, Jinyi Zhang, Katherine A Siminovitch.   

Abstract

The Wiskott-Aldrich syndrome protein (WASp) has emerged as a central player in the regulation of actin remodeling in T cells. The unique domain structure of WASp and other WASp family members enables these proteins to associate with a myriad of signaling effectors and to thereby regulate the coupling of T cell antigen receptor (TCR) engagement to both cytoskeletal rearrangement and transcriptional activation. This review focuses on these biochemical properties of WASp and also on the mechanisms whereby WASp interactions with its cognate ligands influence T cell activation. Because of its capacity to shift intracellular location and thereby dictate both the timing and the spatial distribution of actin polymerization following cell stimulation, WASp is well positioned to play major regulatory roles in directing a wide range of cellular processes and signaling pathways. Further dissection of the functional and biochemical properties of WASp therefore represents a promising avenue towards defining the molecular mechanisms that convey TCR stimulatory signals to the actin cytoskeleton and integrate cytoskeletal and other signaling systems so as to evoke a biological response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670398     DOI: 10.1034/j.1600-065x.2003.00031.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  24 in total

1.  Ubiquitylation-dependent negative regulation of WASp is essential for actin cytoskeleton dynamics.

Authors:  Barak Reicher; Noah Joseph; Ahuvit David; Maor H Pauker; Orly Perl; Mira Barda-Saad
Journal:  Mol Cell Biol       Date:  2012-06-04       Impact factor: 4.272

2.  Signaling by the engulfment receptor draper: a screen in Drosophila melanogaster implicates cytoskeletal regulators, Jun N-terminal Kinase, and Yorkie.

Authors:  John F Fullard; Nicholas E Baker
Journal:  Genetics       Date:  2014-11-12       Impact factor: 4.562

3.  Mechanism and rate constants of the Cdc42 GTPase binding with intrinsically disordered effectors.

Authors:  Xiaodong Pang; Huan-Xiang Zhou
Journal:  Proteins       Date:  2016-03-09

Review 4.  Molecular defects that affect platelet dense granules.

Authors:  Meral Gunay-Aygun; Marjan Huizing; William A Gahl
Journal:  Semin Thromb Hemost       Date:  2004-10       Impact factor: 4.180

5.  Specific patterns of Cdc42 activity are related to distinct elements of T cell polarization.

Authors:  Irina Tskvitaria-Fuller; Abhinav Seth; Neeta Mistry; Hua Gu; Michael K Rosen; Christoph Wülfing
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 6.  RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy.

Authors:  Fang Cheng; Song He
Journal:  Mol Biol Rep       Date:  2009-09-12       Impact factor: 2.316

7.  Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T cell development.

Authors:  Vinicius Cotta-de-Almeida; Lisa Westerberg; Michel H Maillard; Dilek Onaldi; Heather Wachtel; Parool Meelu; Ung-il Chung; Ramnik Xavier; Frederick W Alt; Scott B Snapper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

Review 8.  Formins in development: orchestrating body plan origami.

Authors:  Raymond Liu; Elena V Linardopoulou; Gregory E Osborn; Susan M Parkhurst
Journal:  Biochim Biophys Acta       Date:  2008-10-14

9.  Identification and characterization of a novel splice-site mutation in a patient with Wiskott-Aldrich syndrome.

Authors:  Nuria Andreu; Carmen Carreras; Félix Prieto; Xavier Estivill; Victor Volpini; Cristina Fillat
Journal:  J Hum Genet       Date:  2003-10-18       Impact factor: 3.172

10.  Acute inhibition of selected membrane-proximal mouse T cell receptor signaling by mitochondrial antagonists.

Authors:  Kwangmi Kim; Lin Wang; Inkyu Hwang
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.